Evidence map›Paper›PMID 36982897›Full record

ReviewInternational journal of molecular sciences2023

Molecular Anatomy of the EML4-ALK Fusion Protein for the Development of Novel Anticancer Drugs.

So Yeong Cheon, Sunghark Kwon

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

So Yeong CheonDepartment of Biotechnology, Konkuk University, Chungju 27478, Republic of Korea.
Sunghark KwonDepartment of Biotechnology, Konkuk University, Chungju 27478, Republic of Korea.
Konkuk University · KR

Funding

Konkuk University 2021
6 · The paper itself

Abstract

The

Indexed as

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansLungOncogene Proteins, FusionProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesAntineoplastic AgentsEML4-ALK fusion protein, humanOncogene Proteins, FusionProtein Kinase InhibitorsReceptor Protein-Tyrosine Kinasesanaplastic lymphoma kinaseechinoderm microtubule-associated protein-like 4EML4-ALK fusionkinase inhibitornon-small-cell lung cancer

Identifiers

PMID36982897
PMCPMC10054655
OpenAlexW4327965754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.